Jinxi Huang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol.

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol.

Journal: BMJ open
Published: September 26, 2025

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.

Journal: Scientific reports
Published: January 03, 2025

Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancer.

Efficacy and prognostic factors of PD-1 inhibitors combined with apatinib in advanced diffuse gastric cancer.

Journal: Neoplasma
Published: October 21, 2024

Inhibition of LINC01048 decreases cell proliferation and induces the apoptosis in gastric cancer.

Inhibition of LINC01048 decreases cell proliferation and induces the apoptosis in gastric cancer.

Journal: Discover oncology
Published: October 17, 2024

BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer.

BAP1 regulates HSF1 activity and cancer immunity in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: April 04, 2024

lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.

lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression.

Journal: Acta biochimica et biophysica Sinica
Published: March 06, 2023

The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis.

The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis.

Journal: Frontiers in pharmacology
Published: April 12, 2022

Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

Journal: Frontiers in medicine
Published: January 25, 2022

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer.

Journal: BMC geriatrics
Published: January 18, 2022

Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model.

Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model.

Journal: Journal of oncology
Published: December 03, 2021

Comprehensive evaluation of caloric restriction-induced changes in the metabolome profile of mice.

Comprehensive evaluation of caloric restriction-induced changes in the metabolome profile of mice.

Journal: Nutrition & metabolism
Published: October 29, 2021

LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

Journal: Frontiers in medicine
Published: October 15, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026